This document discusses renal function tests and their importance in assessing kidney function and detecting impairment. It describes various tests including urine analysis, blood tests of creatinine and urea, and glomerular function tests. Common indications for evaluating renal function are listed, such as older age, diabetes, and hypertension. The document also outlines approaches to interpreting test results and diagnosing different kidney conditions like acute injury, nephritic syndrome, and nephrotic syndrome.
A test in which blood or urine samples are checked for the amounts of certain substances released by the kidneys. A higher- or lower-than-normal amount of a substance can be a sign that the kidneys are not working the way they should. Also called kidney function test.
A test in which blood or urine samples are checked for the amounts of certain substances released by the kidneys. A higher- or lower-than-normal amount of a substance can be a sign that the kidneys are not working the way they should. Also called kidney function test.
Renal function tests are very useful for effective clinical evaluation of renal failure for effective management. So it is useful for medical and allied professional students and clinical practitioners.
rft is described in detail . function of kidney, objectives of doing the test. the various test available for assessing the renal function with clinical interpretation is available.
Creatinine clearance may be used as indicator for GFR because:
Creatinine is endogenously produced.
Creatinine is released into body fluid at constant rate.
Its plasma level maintained within narrow limits.
Its plasma level not affected by dietary factors
Renal function test (RFT), also known as kidney function test is a group of tests used to assess the functions of kidney.
It is used screen for, detect, evaluate and monitor acute and chronic kidney diseases.
These are simple blood and urine tests that are used identify kidneys problems.
Tests of renal function have utility in-
Identifying the presence of renal disease
Monitoring the response of kidneys to treatment
Determining the progression of renal disease
RFT is ordered, if your doctor
thinks your kidneys may not be working properly which is known from signs and symptoms
and if you have other conditions that can harm the kidneys, such as diabetes or high blood pressure
Biochemical kidney function tests with their clinical applicationsrohini sane
An illustrative presentation on Biochemical kidney function tests with their clinical applications for medical ,dental, pharmacology and biotechnology student to facilitate easy-learning.
KFT are used for evaluating kidney functions. there are several routine tests such as urea, creatinine and uric acid. Calculation of eGFR is recommended by national kidney organization whenever creatinine serum is measured.
Importance of enzymes : The two aminotransferases that are checked are the alanine aminotransferase (ALT or SGPT) and aspartate aminotransferase (AST or SGOT). These liver enzymes form a major constituent of the liver cells. They are present in lesser concentration in the muscle cells.
The liver is the largest organ in the body
It is located below the diaphragm in the right upper quadrant of the abdominal cavity and extended approximately from the right 5th rib to the lower border of the rib cage.
Renal function tests are very useful for effective clinical evaluation of renal failure for effective management. So it is useful for medical and allied professional students and clinical practitioners.
rft is described in detail . function of kidney, objectives of doing the test. the various test available for assessing the renal function with clinical interpretation is available.
Creatinine clearance may be used as indicator for GFR because:
Creatinine is endogenously produced.
Creatinine is released into body fluid at constant rate.
Its plasma level maintained within narrow limits.
Its plasma level not affected by dietary factors
Renal function test (RFT), also known as kidney function test is a group of tests used to assess the functions of kidney.
It is used screen for, detect, evaluate and monitor acute and chronic kidney diseases.
These are simple blood and urine tests that are used identify kidneys problems.
Tests of renal function have utility in-
Identifying the presence of renal disease
Monitoring the response of kidneys to treatment
Determining the progression of renal disease
RFT is ordered, if your doctor
thinks your kidneys may not be working properly which is known from signs and symptoms
and if you have other conditions that can harm the kidneys, such as diabetes or high blood pressure
Biochemical kidney function tests with their clinical applicationsrohini sane
An illustrative presentation on Biochemical kidney function tests with their clinical applications for medical ,dental, pharmacology and biotechnology student to facilitate easy-learning.
KFT are used for evaluating kidney functions. there are several routine tests such as urea, creatinine and uric acid. Calculation of eGFR is recommended by national kidney organization whenever creatinine serum is measured.
Importance of enzymes : The two aminotransferases that are checked are the alanine aminotransferase (ALT or SGPT) and aspartate aminotransferase (AST or SGOT). These liver enzymes form a major constituent of the liver cells. They are present in lesser concentration in the muscle cells.
The liver is the largest organ in the body
It is located below the diaphragm in the right upper quadrant of the abdominal cavity and extended approximately from the right 5th rib to the lower border of the rib cage.
Genitourinary disorders are conditions that affect the genitourinary system, which includes the urinary and reproductive systems. Some are congenital, and others are acquired later in life.
Large numbers of patients suffer from a variety of diseases in the genitourinary system, which is composed of kidneys, ureters, bladder, urethra, and genital organs. Genitourinary diseases include congenital abnormalities, iatrogenic injuries, and disorders such as cancer, trauma, infection, and inflammation.
PowerPoint presentation reviewing renal failure. The review discusses both acute and chronic renal failure. Etiology, assessment, diagnosis and treatment are discussed.
Health Education on prevention of hypertensionRadhika kulvi
Hypertension is a chronic condition of concern due to its role in the causation of coronary heart diseases. Hypertension is a worldwide epidemic and important risk factor for coronary artery disease, stroke and renal diseases. Blood pressure is the force exerted by the blood against the walls of the blood vessels and is sufficient to maintain tissue perfusion during activity and rest. Hypertension is sustained elevation of BP. In adults, HTN exists when systolic blood pressure is equal to or greater than 140mmHg or diastolic BP is equal to or greater than 90mmHg. The
TOP AND BEST GLUTE BUILDER A 606 | Fitking FitnessFitking Fitness
"Feature:
• Intelligent Ergonomically Design Glute Builder Is A Must Have For Those Looking To Target Their Gluteal Muscles And Hamstrings With Precision.
• The Ability To Adjust The Starting Position, This Machine Allows For A More Targeted Workout That Is Tailored To Your Specific Needs.
• Spacious And Supportive Cushioned Seat Provide Added Comfort And Stability During Your Workout."
Get more information visit on:- www.fitking.in
Our mail I.D:-care@fitking.in, fitking.in@gmail.com
Call us at :- 9958880790, 9870336406, 8800695917
The dimensions of healthcare quality refer to various attributes or aspects that define the standard of healthcare services. These dimensions are used to evaluate, measure, and improve the quality of care provided to patients. A comprehensive understanding of these dimensions ensures that healthcare systems can address various aspects of patient care effectively and holistically. Dimensions of Healthcare Quality and Performance of care include the following; Appropriateness, Availability, Competence, Continuity, Effectiveness, Efficiency, Efficacy, Prevention, Respect and Care, Safety as well as Timeliness.
India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...Kumar Satyam
According to TechSci Research report, "India Clinical Trials Market- By Region, Competition, Forecast & Opportunities, 2030F," the India Clinical Trials Market was valued at USD 2.05 billion in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 8.64% through 2030. The market is driven by a variety of factors, making India an attractive destination for pharmaceutical companies and researchers. India's vast and diverse patient population, cost-effective operational environment, and a large pool of skilled medical professionals contribute significantly to the market's growth. Additionally, increasing government support in streamlining regulations and the growing prevalence of lifestyle diseases further propel the clinical trials market.
Growing Prevalence of Lifestyle Diseases
The rising incidence of lifestyle diseases such as diabetes, cardiovascular diseases, and cancer is a major trend driving the clinical trials market in India. These conditions necessitate the development and testing of new treatment methods, creating a robust demand for clinical trials. The increasing burden of these diseases highlights the need for innovative therapies and underscores the importance of India as a key player in global clinical research.
For those battling kidney disease and exploring treatment options, understanding when to consider a kidney transplant is crucial. This guide aims to provide valuable insights into the circumstances under which a kidney transplant at the renowned Hiranandani Hospital may be the most appropriate course of action. By addressing the key indicators and factors involved, we hope to empower patients and their families to make informed decisions about their kidney care journey.
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...ILC- UK
The Healthy Ageing and Prevention Index is an online tool created by ILC that ranks countries on six metrics including, life span, health span, work span, income, environmental performance, and happiness. The Index helps us understand how well countries have adapted to longevity and inform decision makers on what must be done to maximise the economic benefits that comes with living well for longer.
Alongside the 77th World Health Assembly in Geneva on 28 May 2024, we launched the second version of our Index, allowing us to track progress and give new insights into what needs to be done to keep populations healthier for longer.
The speakers included:
Professor Orazio Schillaci, Minister of Health, Italy
Dr Hans Groth, Chairman of the Board, World Demographic & Ageing Forum
Professor Ilona Kickbusch, Founder and Chair, Global Health Centre, Geneva Graduate Institute and co-chair, World Health Summit Council
Dr Natasha Azzopardi Muscat, Director, Country Health Policies and Systems Division, World Health Organisation EURO
Dr Marta Lomazzi, Executive Manager, World Federation of Public Health Associations
Dr Shyam Bishen, Head, Centre for Health and Healthcare and Member of the Executive Committee, World Economic Forum
Dr Karin Tegmark Wisell, Director General, Public Health Agency of Sweden
CHAPTER 1 SEMESTER V PREVENTIVE-PEDIATRICS.pdfSachin Sharma
This content provides an overview of preventive pediatrics. It defines preventive pediatrics as preventing disease and promoting children's physical, mental, and social well-being to achieve positive health. It discusses antenatal, postnatal, and social preventive pediatrics. It also covers various child health programs like immunization, breastfeeding, ICDS, and the roles of organizations like WHO, UNICEF, and nurses in preventive pediatrics.
India Diagnostic Labs Market: Dynamics, Key Players, and Industry Projections...Kumar Satyam
According to the TechSci Research report titled “India Diagnostic Labs Market Industry Size, Share, Trends, Competition, Opportunity, and Forecast, 2019-2029,” the India Diagnostic Labs Market was valued at USD 16,471.21 million in 2023 and is projected to grow at an impressive compound annual growth rate (CAGR) of 11.55% through 2029. This significant growth can be attributed to various factors, including collaborations and partnerships among leading companies, the expansion of diagnostic chains, and increasing accessibility to diagnostic services across the country. This comprehensive report delves into the market dynamics, recent trends, drivers, competitive landscape, and benefits of the research report, providing a detailed analysis of the India Diagnostic Labs Market.
Collaborations and Partnerships
Collaborations and partnerships among leading companies play a pivotal role in driving the growth of the India Diagnostic Labs Market. These strategic alliances allow companies to merge their expertise, strengthen their market positions, and offer innovative solutions. By combining resources, companies can enhance their research and development capabilities, expand their product portfolios, and improve their distribution networks. These collaborations also facilitate the sharing of technological advancements and best practices, contributing to the overall growth of the market.
Expansion of Diagnostic Chains
The expansion of diagnostic chains is a driving force behind the growing demand for diagnostic lab services. Diagnostic chains often establish multiple laboratories and diagnostic centers in various cities and regions, including urban and rural areas. This expanded network makes diagnostic services more accessible to a larger portion of the population, addressing healthcare disparities and reaching underserved populations. The presence of diagnostic chain facilities in multiple locations within a city or region provides convenience for patients, reducing travel time and effort. A broader network of labs often leads to reduced waiting times for appointments and sample collection, ensuring that patients receive timely and efficient diagnostic services.
Rising Prevalence of Chronic Diseases
The increasing prevalence of chronic diseases is a significant driver for the demand for diagnostic lab services. Chronic conditions such as diabetes, cardiovascular diseases, and cancer require regular monitoring and diagnostic testing for effective management. The rise in chronic diseases necessitates the use of advanced diagnostic tools and technologies, driving the growth of the diagnostic labs market. Additionally, early diagnosis and timely intervention are crucial for managing chronic diseases, further boosting the demand for diagnostic lab services.
2. WHY TEST RENAL FUNCTION?
To asses the functional capacity of kidney
Early detection of possible renal impairment.
Severity and progression of the impairment.
Monitor response to treatment
Monitor the safe and effective use of drugs which
are excreted in the urine
3. WHEN SHOULD WE ASSESS RENAL FUNCTION?
Older age
Family history of Chronic Kidney disease (CKD)
Decreased renal mass
Low birth weight
Diabetes Mellitus (DM)
Hypertension (HTN)
Autoimmune disease
Systemic infections
Urinary tract infections (UTI)
Nephrolithiasis
Obstruction to the lower urinary tract
Drug toxicity
4. WHAT TO EXAMINE???
Renal function tests are divided into the following:
Urine analysis
Blood examination
Glomerular Function Test
5. URINE ANALYSIS
Urine examination is an extremely valuable
and most easily performed test for the
evaluation of renal functions.
It includes physical or macroscopic
examination, chemical examination and
microscopic examination of the sediment.
6. MACROSCOPIC EXAMINATION
Colour
Normal- pale yellow in colour due to pigments
urochrome,urobilin, Cloudiness may be caused by
excessive cellular material or protein, crystallization
or precipitation of salts upon standing at room
temperature or in the refrigerator.
If the sample contains many red blood cells, it
would be cloudy as well as red.
7. COLOR OF URINE
Normal Deep yellow---- conc. Of urochrome pigment
Red Blood, Hemoglobulinuria, myoglobinuria, beetroot ( chukandar)
orange rifampicin
yellow Concentrated urine, ( dehydration, jaundice, B complex,
sulfasalazine)
Green Methylene blue
Black Severe hemoglobinuri, methyldopa
Brown Bilirubin, phenothiazides
8. VOLUME
Normal- 800 ml -2.5 L/day
Oliguria- Urine Output < 300ml/day
Seen in
Acute glomerulonephritis
Renal Failure
Polyuria- Urine Output > 2.5 L/day
Seen in
Increased water ingestion
Diabetes mellitus and insipidus.
Anuria- Urine output < 100ml/day
Seen in renal shut down
9. SPECIFIC GRAVITY
Normal ranges 1.002 – 1.025
Varies with quantity of urine
Low SG
CRF
diabetes insipidus
Absence of ADH
Renal tubular demage
High SG
Dehydration
diabetes mellitus
Albuminuruia
Acute nephritis
10. PH:
Urine pH ranges from 4.5 to 8
Normally it is slightly acidic lying between 6 – 6.5.
After meal it becomes alkaline.
On exposure to atmosphere, urea in urine splits
causing NH4
+ release resulting in alkaline reaction.
11. CHEMICAL EXAMINATION
Glucose:
Diabetes
Impaired Renal tubular
False positive or negative – large dose of vitamin C,
tetracycline or levodopa
Ketones:
Diabetic- diabetic ketoacidosis
Starvation
Protein:
Normal protein loss from urine is less than 150mg
/24 hrs.
12. MICROSCOPIC EXAMINATION
White cell:
More than 10 or more wbc per cm- UTI
Stone, tubulointestinal nephritis, tuberculosis, papillary necrosis
Red cell:
2-5 per high power field – hematuria
Cast:
Cylindrical structure- kidney tubule-coagulation of protein
Hyaline cast: concentrated urine, fever, diuretic therapy, after
exercise
Granular cast: found in chronic glomerulonephritis, diabetic
nephropathy and malignant hypertension
White cell cast: acute pyelonephritis
Red cell cast: glomerulonephritis
Epithelial cast: acute tubular necrosis and interstitial nephritis
15. BLOOD EXAMINATION
Done to measure substance in blood that are
normally excreted by kidney.
Their level in blood increases in kidney dysfunction.
As markers of renal function creatinine, urea,uric
acid and electrolytes are done for routine analysis
16. SERUM CREATININE
Most useful clinical test
Creatinine is the product of muscle metabolism
50% renal function is lost before creatinine is raise
Normal range is 0.8-1.3 mg/dl in men and 0.6-1 mg/dl in women
Increases serum creatinine independent of GFR
Impaired renal function
Very high protein diet
Anabolic steroid users
Vary large muscle mass: body
builders, giants, acromegaly patients
Rhabdomyolysis/crush injury
Athletes taking oral creatine.
Drugs:
• Probenecid
• Cimetidine
Decrease serum creatinine
• Advance age
• Liver disease
17. SERUM UREA
Produce by liver and end product of protein catabolism
Freely filtered by the glomerulus and 30-40 % reabsorbed.
Increase serum urea
Dehydration
Catabolic state
High protein diet
Glucocorticoid
Tetracycline
Low serum urea
Liver disease
Malnutrition
Low protein diet
Old age
18. GLOMERULAR FUNCTION TESTS
Measure the amount of plasma ultra filtered across
glomerular capillaries
Ability of kidney to filter fluids and various
substance
Normal GFR is in the range of 115- 125 ml/mint.
GFR indicate both acute and chronic condition
Inulin clearance and creatinine clearance are used
to measure the GFR.
19. Stage Description (GFR)
At increased risk
Risk factors for kidney disease
(e.g., diabetes, high blood
pressure, family history, older
age, ethnic group)
More than 90
1
Kidney damage with normal
kidney function
90 or above
2
Kidney damage with mild loss of
kidney function
89 to 60
3a
Mild to moderate loss of kidney
function
59 to 44
3b
Moderate to severe loss of kidney
function
44 to 30
4 Severe loss of kidney function 29 to 15
5 Kidney failure Less than 15
21. CLINICAL MANIFESTATIONS OF RENAL
DISEASE
Azotemia: Elevation of blood urea nitrogen and
creatinine levels
Decreased glomerular filtration rate (GFR)
Intrinsic renal disease or extrarenal causes.
Prerenal azotemia is encountered-hypoperfusion of
the kidneys – Decrease GFR in the absence of
parenchymal damage.
Postrenal azotemia results when urine flow is
obstructed below the level of the kidney. Relief of
the obstruction is followed by correction of the
azotemia
22. Azotemia gives rise - uremia.
Uremia is characterized not only by failure of renal –But
metabolic and endocrine alteration
Secondary cause uremic gastroenteritis, peripheral
neuropathy and uremic pericarditis
Azotemia has three classifications, depending on its
causative origin
Decrease in the glomerular filtration rate (GFR) of
the kidneys and increases in blood urea nitrogen (BUN)
and serum creatinine concentrations.
The BUN-to-creatinine ratio (BUN:Cr) is a useful
measure in determining the type of azotemia. A normal
BUN:Cr is equal to 15
23. Prerenal azotemia
decrease in blood flow (hypoperfusion),
hemorrhage, shock,volume depletion, congestive
heart failure, adrenal insufficiency, and narrowing of
the renal artery.
The BUN:Cr in prerenal azotemia is greater than
20.
Primary renal azotemia
intrinsic disease of the kidney, generally the result
of renal parenchymal damage.
The BUN:Cr in renal azotemia is less than 15
Postrenal azotemia
Blockage of urine flow in an area below the kidneys
results in postrenal azotemia
The BUN:Cr in postrenal azotemia is initially >15
24. NEPHRITIC SYNDROME
Glomerular injury and is dominated by the acute
onset
hematuria (red blood cells and red cell casts in
urine),
proteinuria of mild to moderate degree,
azotemia,
edema,
hypertension; it is the classic presentation.
25. NEPHROTIC SYNDROME
Glomerular syndrome
proteinuria (excretion of greater than 3.5 g of
protein/day in adults),
hypoalbuminemia,
severe edema,
hyperlipidemia,
lipiduria (lipid in the urine).
26. RAPIDLY PROGRESSIVE
GLOMERULONEPHRITIS
Rapidly progressive glomerulonephritis is
associated with severe glomerular injury
loss of renal function in a few days or weeks.
Microscopic hematuria,
dysmorphic red blood cells and red cell casts in the
urine sediment,
Mild to moderate proteinuria.
27. ACUTE KIDNEY INJURY
Oliguria or anuria (no urine flow),
Recent onset of azotemia.
It can result from glomerular injury (such as rapidly
progessive glomerulonephritis), interstitial injury,
vascular injury (such as thrombotic
microangiopathy), or acute tubular injury.
Chronic kidney disease,
prolonged symptoms and signs of uremia, is the
result of progressive scarring in the kidney from any
cause and may culminate in end-stage kidney
disease, requiring dialysis or transplantation.
28. URINARY TRACT INFECTION
Bacteriuria and pyuria (bacteria and leukocytes in
the urine).
The infection may be symptomatic or
asymptomatic, and it may affect the kidney
(pyelonephritis) or the bladder (cystitis) only.
Nephrolithiasis (renal stones) is manifested by renal
colic, hematuria (without red cell casts), and
recurrent stone formation
32. Plain X-ray:
Renal calcification or radiodense calculi
Outline of ureters and bladder
Radionuclide Studies:
99mTc- DTPA
Access GFR when urine collection is difficult or expected inaccurate
Helpful in the diagnosis of renal artery stenosis
Localized the site of obstruction
99mTc-DMSA
Determine the contribution of each kidney to overall renal function.
Localized infection such as renal abscess
33. CT SCAN:
CT scan shows kidney, ureters and surrounding tissue in detail and
is useful in the diagnosis of renal tumors.
MRI:
Differentiation between cystic and solid renal masses. MR
angiography of renal arteries is increasingly used to screen for renal
arterial disease.
Arteriography and Venography
Excretion urography (IVP )
Antegrade urography
Retrograde urography
Renal BIPSY
34. INDICTION OF RENAL BIOPSY
Adult nephritic syndrome
Persistent proteinuria > 1g/24 hr
Persistent microscopic and macroscopic hematuria
Systemic disease with renal involvement such as
amyloidosis
Chronic renal failure with normal size of kidney
Unexplained kidney failure
Childhood nephritic syndrome